Additional information on peripherally induced movement disorders
| Nerve lesion identified by (n (%))* (n=182) | |
| Electrophysiology | 50 (27) |
| Imaging | 17 (9) |
| Neurological examination | 21 (12) |
| Operation | 24 (13) |
| Unspecified | 70 (38) |
| Pain (n (%))* (n=568) | |
| Before start of movement disorder | 132 (23) |
| Simultaneous with start of movement disorder | 225 (40) |
| Present, but time unknown | 186 (33) |
| Not present | 25 (4) |
| Sensory signs (n (%))* (n=301) | |
| Hypo (hypalgesia) | 94 (31) |
| Hyper (allodynia, hyperalgesia) | 83 (28) |
| Both | 45 (15) |
| Altered sensation, type deficit not described | 79 (26) |
| Psychological aspects (n (%))* (n=258) | |
| Present | 84 (33) |
| Not present | 174 (67) |
| Litigation (n (%))* (n=200) | |
| Involved in litigation/worker's compensation | 66 (33) |
| Not involved in litigation | 134 (67) |
| Treatment with BoNT (n (%))* (n=133) | |
| Successful | 26 (20) |
| Partly successful | 75 (56) |
| Passive successful | 3 (2) |
| Unsuccessful | 29 (22) |
| Predisposing factors (n (%))* (n=265) | |
| Family history of similar movement disorder | 15 (6) |
| Family history of other movement disorder | 6 (2) |
| Drug abuse | 1 (0) |
| Premature birth | 1 (0) |
| Developmental delay | 1 (0) |
| Other | 27 (10) |
| No predisposing factors | 214 (81) |
n, number of patients on which this information was available; (%) refers to whole group unless otherwise specified.
↵* Percentage calculated for the number of patients on which the information was available.
BoNT, botulinum toxin.